TriangleDISEASE & TREATMENT SETTING
Pituitary Tumors
Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.
Exact scope
Pituitary Tumors
- Source population
- Not part of this definition
- Disease extent
- Not part of this definition
- Treatment line
- Not part of this definition
- Stage
- Not part of this definition
- Resectability
- Not part of this definition
Biomarkers, prior therapy and derivation
- molecular
- prior therapy
- derivation status
- clinically-proposed
- derivation note
- Derived from NCI topic(s): Pituitary Tumors. Strongest NCIt resolution: candidate. Entity-level scope; stage, biomarker and treatment line are not yet part of this definition.
- source wording
- Source null
1 more-specific settings
Study evidence for this setting
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Barrow Nasal Inventory Survey
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
Da Vinci Transoral Robotic-assisted Surgery of Pituitary Gland
Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors
Source relationships and population-mapping limitations
- bindings
- release id
- clinical-indications-draft-1
- disease state id
- ds-pituitary-tumors
- binding id
- ncit-C3330
- source collection
- ncit-concept
- source key
- C3330
- source excerpt
- Source null
- match status
- candidate
- match note
- Resolution status: candidate.
- recorded at
- 2026-09-10T00:00:00Z
- mappings
Download this complete draft source relationship record →
Preserved source evidence · Not medical advice